The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans

F Storelli, M Yin, AR Kumar, MK Ladumor… - Pharmacology & …, 2022 - Elsevier
… in the liver, blood-brain barrier), predicting TC is important to … IVIVE scaling approaches
to predict transporter-based CL, … approaches can be used to predict transporter-based DDI. …

Prediction of human pharmacokinetics—renal metabolic and excretion clearance

U Fagerholm - Journal of Pharmacy and Pharmacology, 2007 - Wiley Online Library
… and show regional differences in enzymatic and transporter activities. This limits the … sound
rationale, enables more accurate and precise predictions of hepatic CL (CLH) and VD to be …

[HTML][HTML] Physiologically based pharmacokinetic modeling of rosuvastatin to predict transporter-mediated drug-drug interactions

N Hanke, JD Gómez-Mantilla, N Ishiguro… - Pharmaceutical …, 2021 - Springer
… protein 2 (MRP2), an efflux transporter at the apical membranes of liver, kidney, gastrointestinal
tract and placenta similar to BCRP. The model could be extended to include these …

In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation

Y Bi, E Kimoto, S Sevidal, HM Jones, HA Barton… - Drug Metabolism and …, 2012 - ASPET
… , SCHHs maintain hepatic transporter expression and functional activity and appear to be a
well characterized an in vitro model for the prediction of in vivo human pharmacokinetics. Rif …

Transport vs. metabolism: what determines the pharmacokinetics and pharmacodynamics of drugs? Insights from the extended clearance model

G Patilea‐Vrana, JD Unadkat - Clinical Pharmacology & …, 2016 - Wiley Online Library
transporters) determine the hepatic clearance of a drug … The ECM can help predict whether
transporters or metabolic … of DDIs and SNPs on these predictions (Table 1, Supplementary S4…

Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake

M Baker, T Parton - Xenobiotica, 2007 - Taylor & Francis
… of predicted hepatic clearance (CL H , predicted from … with no adjustment for being a transporter
substrate) and the fraction … Prediction of pharmacokinetic properties using experimental …

Toward prospective prediction of pharmacokinetics in OATP1B1 genetic variant populations

R Li, HA Barton, TS Maurer - CPT: Pharmacometrics & Systems …, 2014 - Wiley Online Library
predict human PK of OATP1B1 substrates for carriers of SLCO1B1 variants through
physiologically based pharmacokinetic (… the ability to predict the pharmacokinetics in the liver, …

A generic model for quantitative prediction of interactions mediated by efflux transporters and cytochromes: application to P-glycoprotein and cytochrome 3A4

M Tod, S Goutelle, N Bleyzac, L Bourguignon - Clinical Pharmacokinetics, 2019 - Springer
… The transporter is assumed to be present in the gut wall, liver (on the apical canalicular
membrane), and kidney (on the apical membrane), resulting in drug secretion in the gut lumen, …

The impact of hepatic uptake on the pharmacokinetics of organic anions

P Gardiner, SW Paine - Drug metabolism and disposition, 2011 - ASPET
… with the liver levels could be quantitatively predicted by … hepatic uptake transporters may
lead to changes in V ss and species differences in the transporters may lead to poor predictions

Physiologically based pharmacokinetic modeling of transporter-mediated hepatic clearance and liver partitioning of OATP and OCT substrates in cynomolgus …

BL Morse, JG MacGuire, AM Marino, Y Zhao, M Fox… - The AAPS Journal, 2017 - Springer
… In the present investigations, we evaluate in vitro hepatocyte uptake and partitioning for
the prediction of in vivo clearance and liver partitioning. Monkeys were intravenously co-dosed …